secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2026-07-01T20:23:22+00:00
Accession:  0000885590-26-000089
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Michael Goettler resigns from Bausch Health board to become CEO of Knoa Pharma
--------------------------------------------------------------------------------

- Resignation effective June 30, 2026, due to appointment as President and CEO of Knoa Pharma LLC.
- Mr. Goettler's departure was not due to any disagreement with the company.
- Press release announcing the resignation was issued on July 1, 2026.
- No other material changes to the board or management disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000088559026000089/0000885590-26-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000088559026000089/bhc-20260626.htm
  HTML page:      https://secwatch.observer/filing/0000885590-26-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer